IPM vs REGN
Intelligent Protection Management Corp (IPM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Intelligent Protection Management Corp (IPM) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported IPM revenue for 2024-12-31 was $1.1M. Net income was -$8.4M. Revenue was up 14.2% from 2023-12-31 to 2024-12-31. IPM currently screens at market cap $28.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
IPM currently screens at market cap $28.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the IPM and REGN stock pages for the full models.
Not investment advice.